Condition category
Mental and Behavioural Disorders
Date applied
19/11/2015
Date assigned
20/11/2015
Last edited
20/11/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Plain English summary under review.

Trial website

Contact information

Type

Public

Primary contact

Mr Moise Roche

ORCID ID

Contact details

University College London
Division of Psychiatry
Maple House
149 Tottenham Court Road
London
W1T 7NF
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

20077

Study information

Scientific title

Improving dementia care in African and Caribbean minority ethnic groups

Acronym

IDEMCARE

Study hypothesis

The aim of this study is to benefit patients and their family carers by increasing timely diagnosis of dementia in Black African and Caribbean groups and thus allowing choice, symptomatic treatment, reduce carers’ depression, avoid crises, and delay care home admission.

Ethics approval

First Medical Research Ethics Committee, 31/03/2014, ref: 14/EE/0136

Study design

Randomised; Interventional; Design type: Process of Care

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Topic: Primary Care; Subtopic: Dementias and neurodegeneration (DeNDRoN); Disease: All Diseases

Intervention

Leaflet, "Getting help for forgetfulness" leaflet has been developed through focus groups and interviews with members of the Black African and Caribbean ethnic minorities. It is a psychoeducation tool aimed changing attitudes to help-seeking for memory problems.

Intervention type

Other

Phase

Drug names

Primary outcome measures

APEND questionnaire; Timepoint(s): 2 weeks and 4 months

Secondary outcome measures

Not provided at time of registration

Overall trial start date

16/11/2015

Overall trial end date

30/04/2016

Reason abandoned

Eligibility

Participant inclusion criteria

Phase 1:
1. Aged 18 or over
2. Community group members who are from Black African or Carribean Minority Ethic groups who have given us permission to approach their members
3. Capacity to consent to participate

Phase 2:
1. Participants of phase 1 of the study who have agreed to be approached again
2. Family people with mild dementia
3. Capacity to consent to participate

Phase 3:
1. Black African or Carribean people who are registered with a GP
2. Aged 50 years or over
3. Able to provide consent to take part in the study

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

Planned Sample Size: 94; UK Sample Size: 94

Participant exclusion criteria

People who do not consent to participate or who lack capacity to consent to involvement in the study.

Recruitment start date

16/11/2015

Recruitment end date

30/04/2016

Locations

Countries of recruitment

United Kingdom

Trial participating centre

University College London
Division of Psychiatry Maple House 149 Tottenham Court Road
London
W1T 7NF
United Kingdom

Sponsor information

Organisation

University College London

Sponsor details

Department of Molecular Pathology
Gower Street
London
WC1E 6BT
United Kingdom

Sponsor type

Hospital/treatment centre

Website

Funders

Funder type

Government

Funder name

National Institute for Health Research

Alternative name(s)

NIHR

Funding Body Type

government organisation

Funding Body Subtype

Federal/National Government

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes